Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideki Furuya

Showing results (21-30 of 77) with videos related to

Pageof 8
Sort By:
Oncotarget|June 19, 2016
Angiogenin contributes to bladder cancer tumorigenesis by DNMT3b-mediated MMP2 activationRafael Peres, Hideki Furuya, Ian Pagano, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 11, 2017
Urinary Protein Markers for the Detection and Prognostication of Urothelial CarcinomaTibor Szarvas, Péter Nyirády, Osamu Ogawa, et al.
Hawai'I Journal of Health & Social Welfare|October 18, 2021
Case Study of Noni Extract in Men with Very Low-Risk or Low-Risk Prostate CancerYosuke Hirasawa, Ian Pagano, Jeffrey Huang, et al.
Diagnostics (Basel, Switzerland)|July 2, 2021
Influencing Factors on the Oncuria™ Urinalysis Assay: An Experimental ModelKaoru Murakami, Ian Pagano, Runpu Chen, et al.
Practical Laboratory Medicine|December 9, 2020
Analytical validation of ONCURIA™ a multiplex bead-based immunoassay for the non-invasive bladder cancer detectionHideki Furuya, Lindlelyn Tabula, Riko Lee, et al.
Diagnostics (Basel, Switzerland)|July 29, 2025
Expanded Performance Comparison of the Oncuria 10-Plex Bladder Cancer Urine Assay Using Three Different Luminex xMAP InstrumentsSunao Tanaka, Takuto Shimizu, Ian Pagano, et al.
Diagnostics (Basel, Switzerland)|November 2, 2019
Comparison of Commercial ELISA Kits, a Prototype Multiplex Electrochemoluminescent Assay, and a Multiplex Bead-Based Immunoassay for Detecting a Urine-Based Bladder-Cancer-Associated Diagnostic SignatureHideki Furuya, Ian Pagano, Keanu Chee, et al.
Research Square|December 4, 2023
Bladder cancer risk stratification with the Oncuria 10-plex bead-based urinalysis assay using three different Luminex xMAP instrumentation platformsHideki Furuya, Toru Sakatani, Sunao Tanaka, et al.
Journal of Translational Medicine|January 3, 2024
Bladder cancer risk stratification with the Oncuria 10-plex bead-based urinalysis assay using three different Luminex xMAP instrumentation platformsHideki Furuya, Toru Sakatani, Sunao Tanaka, et al.
Springerplus|November 7, 2015
CXCL1 is elevated in the urine of bladder cancer patientsAndre Burnier, Yoshiko Shimizu, Yunfeng Dai, et al.
Pageof 8

Showing results (21-30 of 77) with videos related to

Sort By:
Pageof 8
Oncotarget|June 19, 2016
Angiogenin contributes to bladder cancer tumorigenesis by DNMT3b-mediated MMP2 activationRafael Peres, Hideki Furuya, Ian Pagano, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 11, 2017
Urinary Protein Markers for the Detection and Prognostication of Urothelial CarcinomaTibor Szarvas, Péter Nyirády, Osamu Ogawa, et al.
Hawai'I Journal of Health & Social Welfare|October 18, 2021
Case Study of Noni Extract in Men with Very Low-Risk or Low-Risk Prostate CancerYosuke Hirasawa, Ian Pagano, Jeffrey Huang, et al.
Diagnostics (Basel, Switzerland)|July 2, 2021
Influencing Factors on the Oncuria™ Urinalysis Assay: An Experimental ModelKaoru Murakami, Ian Pagano, Runpu Chen, et al.
Practical Laboratory Medicine|December 9, 2020
Analytical validation of ONCURIA™ a multiplex bead-based immunoassay for the non-invasive bladder cancer detectionHideki Furuya, Lindlelyn Tabula, Riko Lee, et al.
Diagnostics (Basel, Switzerland)|July 29, 2025
Expanded Performance Comparison of the Oncuria 10-Plex Bladder Cancer Urine Assay Using Three Different Luminex xMAP InstrumentsSunao Tanaka, Takuto Shimizu, Ian Pagano, et al.
Diagnostics (Basel, Switzerland)|November 2, 2019
Comparison of Commercial ELISA Kits, a Prototype Multiplex Electrochemoluminescent Assay, and a Multiplex Bead-Based Immunoassay for Detecting a Urine-Based Bladder-Cancer-Associated Diagnostic SignatureHideki Furuya, Ian Pagano, Keanu Chee, et al.
Research Square|December 4, 2023
Bladder cancer risk stratification with the Oncuria 10-plex bead-based urinalysis assay using three different Luminex xMAP instrumentation platformsHideki Furuya, Toru Sakatani, Sunao Tanaka, et al.
Journal of Translational Medicine|January 3, 2024
Bladder cancer risk stratification with the Oncuria 10-plex bead-based urinalysis assay using three different Luminex xMAP instrumentation platformsHideki Furuya, Toru Sakatani, Sunao Tanaka, et al.
Springerplus|November 7, 2015
CXCL1 is elevated in the urine of bladder cancer patientsAndre Burnier, Yoshiko Shimizu, Yunfeng Dai, et al.
Pageof 8